Sanuwave Health Inc.
SNWV Healthcare Medical Devices
Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024. In the quarter to June 2026, revenue fell 3.13%, EPS fell 224.2%, free cash flow grew 86.8% and total debt fell 28.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow SNWV
Sanuwave Health Inc. (SNWV) P/E ratio
As of 16 October 2026, Sanuwave Health Inc. (SNWV) trades at a P/E ratio of 3.0×. Over the past ten years it has ranged from 0.0× (December 2025) to 23.6× (January 2026); the current reading is higher than 58% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 22.7× | — |
| FY2024 | 0.0× | — |
| FY2023 | 2.5× | 0.00% |
| FY2022 | 2.5× | 0.00% |
| FY2021 | 2.5× | 0.00% |
| FY2020 | 2.5× | 0.00% |
| FY2019 | 2.5× | 0.00% |
| FY2018 | 2.5× | 0.00% |
| FY2017 | 2.5× | 0.00% |
| FY2016 | 2.5× | 0.00% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 6.0× | (37.13%) |
| Mar 2026 | 9.6× | (57.79%) |
| Dec 2025 | 22.7× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TELA TELA Bio, Inc. compare | n/m |
| MDAI Spectral AI, Inc. compare | n/m |
| NNOX Nano-X Imaging Ltd. compare | n/m |
| TLIS Talis Biomedical Corporation compare | n/m |
| RPID Rapid Micro Biosystems, Inc. compare | n/m |
| SRTS Sensus Healthcare, Inc. compare | n/m |
| XTNT Xtant Medical Holdings, Inc. compare | n/m |
| COCH Envoy Medical, Inc. compare | n/m |
| SNWV Sanuwave Health Inc. | 3.0× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)